71
TITLE: Why healthy subjects volunteer for phase I studies and how they perceive their participation?  Full Text
AUTHORS: Luis Almeida; Benedita Azevedo; Teresa Nunes; Manuel Vaz da Silva ; Patricio Soares da Silva ;
PUBLISHED: 2007, SOURCE: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 63, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 53
IN MY: ORCID
72
TITLE: Catechol-O-methyltransferase and its inhibitors in Parkinson's disease  Full Text
AUTHORS: Bonifacio, MJ; Palma, PN; Almeida, L; Soares Da Silva, P ;
PUBLISHED: 2007, SOURCE: CNS DRUG REVIEWS, VOLUME: 13, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 162
IN MY: ORCID
73
TITLE: Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker  Full Text
AUTHORS: Falcao, A ; Maia, J; Almeida, L; Mazur, D; Gellert, M; Soares Da Silva, P ;
PUBLISHED: 2007, SOURCE: BIOPHARMACEUTICS & DRUG DISPOSITION, VOLUME: 28, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 43
IN MY: ORCID
74
TITLE: Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures  Full Text
AUTHORS: Christian Elger; Meir Bialer; Joyce A Cramer; Joana Maia; Luis Almeida; Patricio Soares da Silva ;
PUBLISHED: 2007, SOURCE: EPILEPSIA, VOLUME: 48, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 105
IN MY: ORCID
75
TITLE: Eslicarbazepine acetate (BIA 2-093)  Full Text
AUTHORS: Luis Almeida; Patricio Soares da Silva ;
PUBLISHED: 2007, SOURCE: NEUROTHERAPEUTICS, VOLUME: 4, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 151
IN MY: ORCID
76
TITLE: Human metabolism of nebicapone (BIA3-202), a novel catechol-O-methyltransferase inhibitor: Characterization of in vitro glucuronidation
AUTHORS: Loureiro, AI; Bonifacio, MJ; Fernandes Lopes, C; Almeida, L; Wright, LC; Soares Da Silva, P ;
PUBLISHED: 2006, SOURCE: DRUG METABOLISM AND DISPOSITION, VOLUME: 34, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 21
IN MY: ORCID
77
TITLE: Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects
AUTHORS: Almeida, L; Falcao, A ; Maia, J; Mazur, D; Gellert, M; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 45, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 84
IN MY: ORCID
78
TITLE: Biological behaviour of Bonelike (R) graft implanted in the tibia of humans
AUTHORS: Gutierres, M ; Hussain, NS; Afonso, A; Almeida, L; Cabral, T; Lopes, MA ; Santos, JD ;
PUBLISHED: 2005, SOURCE: 17th International Symposium on Ceramics in Medicine in BIOCERAMICS, VOL 17, VOLUME: 284-286
INDEXED IN: Scopus WOS CrossRef: 13
79
TITLE: Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions  Full Text
AUTHORS: Vaz da Silva, M ; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcao, A ; Silveira, P; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: CLINICAL DRUG INVESTIGATION, VOLUME: 25, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID
80
TITLE: Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093)  Full Text
AUTHORS: Maia, J; Vaz Da Silva, M ; Almeida, L; Falcao, A; Silveira, P; Guimaraes, S; Graziela, P; Soares Da Silva, P ;
PUBLISHED: 2005, SOURCE: Drugs in R and D, VOLUME: 6, ISSUE: 4
INDEXED IN: Scopus CrossRef: 43
IN MY: ORCID
Page 8 of 10. Total results: 92.